Free Trial

Ocugen (OCGN) News Today

Ocugen logo
$0.74 +0.02 (+3.40%)
Closing price 04:00 PM Eastern
Extended Trading
$0.73 -0.01 (-0.95%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Ocugen says DSMB approves dosing Cohort 2 in OCU200 clinical trial
Ocugen, Inc. stock logo
HC Wainwright Forecasts Ocugen's Q1 Earnings (NASDAQ:OCGN)
Ocugen, Inc. (NASDAQ:OCGN - Free Report) - Stock analysts at HC Wainwright reduced their Q1 2025 earnings estimates for shares of Ocugen in a research note issued on Thursday, March 6th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($0.05) per share for the quarter, d
Ocugen, Inc. stock logo
Equities Analysts Offer Predictions for Ocugen Q1 Earnings
Ocugen, Inc. (NASDAQ:OCGN - Free Report) - Investment analysts at HC Wainwright cut their Q1 2025 EPS estimates for Ocugen in a research report issued on Thursday, March 6th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings of ($0.05) per share for the quarter,
Ocugen, Inc. stock logo
What is HC Wainwright's Estimate for Ocugen FY2029 Earnings?
Ocugen, Inc. (NASDAQ:OCGN - Free Report) - Stock analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for shares of Ocugen in a research note issued to investors on Thursday, March 6th. HC Wainwright analyst S. Ramakanth forecasts that the company will post earnings pe
Ocugen, Inc. stock logo
Chardan Capital Issues Positive Forecast for Ocugen (NASDAQ:OCGN) Stock Price
Chardan Capital lifted their price target on Ocugen from $6.00 to $7.00 and gave the stock a "buy" rating in a report on Thursday.
Ocugen, Inc. stock logo
Ocugen (NASDAQ:OCGN) Receives "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $8.00 price objective on shares of Ocugen in a research report on Thursday.
Ocugen, Inc. stock logo
Ocugen (NASDAQ:OCGN) Announces Quarterly Earnings Results, Hits Estimates
Ocugen (NASDAQ:OCGN - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.05) earnings per share for the quarter, hitting the consensus estimate of ($0.05). Ocugen had a negative net margin of 532.51% and a negative return on equity of 154.75%. During the same period in the previous year, the firm earned ($0.03) EPS.
Ocugen reports Q4 EPS (5c), consensus (5c)
Noble Financial Sticks to Its Buy Rating for Ocugen (OCGN)
Ocugen, Inc. stock logo
Ocugen (OCGN) Expected to Announce Earnings on Wednesday
Ocugen (NASDAQ:OCGN) will be releasing earnings before the market opens on Wednesday, March 5, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=669102)
Ocugen, Inc. stock logo
What is HC Wainwright's Forecast for Ocugen FY2024 Earnings?
Ocugen, Inc. (NASDAQ:OCGN - Free Report) - Equities researchers at HC Wainwright increased their FY2024 earnings per share (EPS) estimates for shares of Ocugen in a research note issued to investors on Thursday, February 13th. HC Wainwright analyst S. Ramakanth now anticipates that the company wi
Ocugen, Inc. stock logo
What is HC Wainwright's Estimate for Ocugen FY2024 Earnings?
Ocugen, Inc. (NASDAQ:OCGN - Free Report) - HC Wainwright increased their FY2024 earnings per share estimates for Ocugen in a research note issued on Thursday, February 13th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings of ($0.17) per share for the year, up fr
Ocugen price target raised to $8 from $7 at H.C. Wainwright
Why Ocugen (OCGN) Is Advancing Today
Ocugen, Inc. stock logo
Ocugen's (OCGN) "Buy" Rating Reiterated at Chardan Capital
Chardan Capital reiterated a "buy" rating and set a $6.00 price target on shares of Ocugen in a report on Thursday.
Ocugen, Inc. stock logo
Ocugen (NASDAQ:OCGN) Given New $8.00 Price Target at HC Wainwright
HC Wainwright upped their price target on shares of Ocugen from $7.00 to $8.00 and gave the stock a "buy" rating in a research report on Thursday.
Ocugen announces dosing completion in Phase 2 ArMaDa clinical trial
Ocugen files to sell 57.54M shares of common stock for holders
Ocugen announces IND in effect after FDA review
Ocugen, Inc. stock logo
Ocugen's (OCGN) Buy Rating Reaffirmed at Chardan Capital
Chardan Capital reissued a "buy" rating and set a $6.00 target price on shares of Ocugen in a research report on Thursday.
Ocugen, Inc. stock logo
Ocugen (NASDAQ:OCGN) Receives "Buy" Rating from Chardan Capital
Chardan Capital reaffirmed a "buy" rating and set a $6.00 price objective on shares of Ocugen in a report on Thursday.
Ocugen announces first patient dosed in Phase 1 OCU200 trial for DME
Remove Ads
Get Ocugen News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCGN and its competitors with MarketBeat's FREE daily newsletter.

OCGN Media Mentions By Week

OCGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OCGN
News Sentiment

1.05

0.89

Average
Medical
News Sentiment

OCGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OCGN Articles
This Week

1

5

OCGN Articles
Average Week

Remove Ads
Get Ocugen News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:OCGN) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners